期刊文献+

盐酸莫西沙星泡腾片的制备及质量控制 被引量:6

Preparation and Quality Control of Moxifloxacin Hydrochloride Effervescent Tablet
原文传递
导出
摘要 目的:制备盐酸莫西沙星泡腾片并建立其质量控制方法。方法:采用酸、碱原料分开法制备泡腾片;以高效液相色谱法测定其中主药含量。结果:所制制剂性状、鉴别、检查等均符合2005年版《中国药典》相关规定;盐酸莫西沙星进样量线性范围为0.4~3.0μg(r=0.9999);平均回收率为98.60%(RSD=0.57%,n=3)。结论:本制剂组方合理,制备工艺简便可行,质量稳定可控。 OBJECTIVE: To prepare moxifloxacin hydrochloride effervescent tablet and to establish a method for its quality control. METHODS: The tablet was prepared with acid resource and base resource respectively. The content of moxifloxacin was determined by HPLC. RESULTS: The preparation obtained was in conformity with the standard recommended by China Pharmacopeia (2005 edition) in description, identification, tests etc. The linear range of moxifloxacin was 0.4~ 3.0μg(r = 0.999 9) and its average recovery was 98.60% (RSD = 0.57%, n = 3) . CONCLUSION: The preparation is reasonable in formula, simple in technique, stable and reliable in quality.
机构地区 河南省人民医院
出处 《中国药房》 CAS CSCD 北大核心 2007年第19期1486-1487,共2页 China Pharmacy
关键词 盐酸莫西沙星 泡腾片 制备 质量控制 Moxifolxacin hydrochloride Effervescent tablets Preparation Quality control
  • 相关文献

参考文献3

二级参考文献14

  • 1杨亚兰,王静,张贵敏.亲水凝胶制剂的研究与应用[J].河北医科大学学报,2005,26(2):159-160. 被引量:7
  • 2Blondeau JM.A review of the comparative in-vitro activities of 12 antimicrobial agents,with a focus on five new "respiratory quinolones"[J].JAntimicrob Chemother,1999,43(suppl B):1.
  • 3Malhotra HS, Perry CM, Ormrod D. Management of acute bacterial exacerbations of chronic bronchitis[J]. Dis Manage Hea Outcomes,2002,10 : 55-70.
  • 4Wilson R, Allegra L, Huchon G, et al. Short-term and longterm outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbation of chronic bronchitis[J].Chest, 2004, 125: 953-964.
  • 5Bauer T, Landen H. Rapid resolution of symptoms with moxifloxacin therapy in 7223 patients with acute exacerbation of chronic bronchitis [ J]. Clin Drug Invest, 2002,22:641-651.
  • 6Mandell LA,Bartlett JG,Dowell SF, et al. Update of practice guidelines for management of community-acquied pneumonia in immunocompetent adults [ J ]. Clin Infect Dis, 2003, 37:1405-1433.
  • 7Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia Diagnosis, assessment of severity, antimicrobial therapy and prevention[J]. Am J respir Crit Care Med, 2001,163:1730-1754
  • 8李眉.第四代喹诺酮类抗菌药物的研究进展[J].中国新药杂志,1999,8(1):11-14. 被引量:13
  • 9孙忠实.莫西沙星[J].中国新药杂志,2000,9(10):722-723. 被引量:25
  • 10朱斌,胡昌勤,蒋受军,尹利辉.高效液相色谱法测定莫西沙星制剂含量[J].中国抗生素杂志,2002,27(8):462-464. 被引量:28

共引文献49

同被引文献48

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部